Neal Masia

Market Access

Today's podcast with Entity Risk's Neal Masia includes insights on the 340B Program, PBMs, and risk-based contracts.

Oncology

For years, ADCs have been positioned as an important addition to the oncology toolkit. But, could they eventually replace chemotherapy altogether?

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.